The AlphaLISA® SureFire® Ultra™ Human Total TREM2 assay is a sandwich immunoassay for quantitative detection of total TREM2 in cellular lysates using Alpha Technology.
The Triggering Receptor Expressed on Myeloid Cells 2 (TREM-2) family of receptors is implicated in the regulation of the immune system's numerous cell types, such as neutrophils, monocyte/macrophages, microglia, and dendritic cells. Human cerebrospinal fluid (CSF) has been shown to include soluble TREM-2, which has been reported to be increased in people with multiple sclerosis and other inflammatory neurological illnesses compared to those without such conditions.
The AlphaLISA SureFire Human Total TREM2 Detection Kit is a sandwich immunoassay for the quantitative detection of total TREM2 in cellular lysates, using Alpha Technology.
For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Application |
Protein Detection
|
---|---|
Assay Technology |
Alpha
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Method |
Alpha
|
Experimental Type |
In vitro
|
Target Species |
Human
|
Therapeutic Area |
Neuroscience
|
Unit Size |
500 Assay Points
|
This guide outlines further possible optimization of cellular and immunoassay parameters to ensure the best possible results are...
Emerging pathways to neuroinflammation and neurodegeneration
Neurodegenerative diseases, such as amyotrophic lateral sclerosis...
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
We are here to answer your questions.